Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

BeauTop improves hair growth in androgenetic alopecia patients.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

New research is helping develop better treatments for alopecia areata.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

PRP did not significantly regrow hair in alopecia areata totalis patients.

PRP therapy and minoxidil combo works best for male hair loss.